Follow
iryna myrko
iryna myrko
Verified email at meduniv.lviv.ua
Title
Cited by
Cited by
Year
QSAR modeling for antioxidant activity of novel N3 substituted 5,7-dimethyl-3h-thiazolo[4,5-b]pyridin-2-ones
O Klenina, T Chaban, V Ogurtsov, I Myrko, B Zimenkovsky, S Harkov, ...
Farmatsija 64 (4), 49-71, 2017
342017
Synthesis of some new 4-iminothiazolidine-2-ones as possible antioxidants agents
T Chaban, V Ogurtsov, I Chaban, I Myrko, S Harkov, M Lelyukh
Pharmacia 66 (1), 27-32, 2019
112019
Synthesis of some new 4-iminothiazolidine-2-ones as possible antioxidants agents. Pharmacia 2019, 66, 27-32
T Chaban, V Ogurtsov, I Chaban, I Myrko, S Harkov, M Leluykh
11
Synthesis of some new 4-iminothiazolidine-2-ones as possible antioxidants agents. Pharmacia66 (1): 27-32
T Chaban, V Ogurtsov, I Chaban, I Myrko, S Harkov, M Leluykh
62019
Synthesis and evaluation of anti-inflammatory activity of some thiazolo [4, 5-b] pyridines
T Chaban, V Matiychuk, Z Chulovska, I Myrko, I Drapak, R Sogujko, ...
Biointerface Res. Appl. Chem 12, 7226-7238, 2021
52021
Approaches for the synthesis, chemical modification and biological properties of N-acylphenothiazines
I Myrko, T Chaban, Y Matiichuk, M Arshad, V Matiychuk
Current Chemistry Letters 10 (4), 377-392, 2021
52021
Anti-inflammatory properties of some novel thiazolo [4, 5-b] pyridin-2-ones
T Chaban, V Matiychuk, O Komarytsya, I Myrko, I Chaban, V Ogurtsov, ...
Pharmacia 67 (3), 121-127, 2020
52020
Current trends of chemoinformatics and computer chemistry in drug design: A review
I Myrko, T Chaban, Y Demchuk, Y Drapak, I Chaban, I Drapak, M Pankiv, ...
Current Chemistry Letters 13 (1), 151-162, 2024
12024
Synthesis and biological evaluation of some new 7H-[1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazines as antimicrobial agents
I Myrko, T Chaban, V Matiychuk
Current Chemistry Letters 11 (1), 75-82, 2022
12022
ÑÈÍÒÅÇ ÒÀ ÄÎÑ˲ÄÆÅÍÍß ÀÍÒÈ̲ÊÐÎÁÍί ÀÊÒÈÂÍÎÑÒ² ÄÅßÊÈÕ Ï²ÐÀÇÎËÇÀ̲ÙÅÍÈÕ 7H-[1, 2, 4] ÒÐÈÀÇÎËÎ [3, 4-B][1, 3, 4] Ò²ÀIJÀÇÈͲÂ
II Myrko, TI Chaban, VV Ogurtsov, VS Matiychuk
Ôàðìàöåâòè÷íèé ÷àñîïèñ, 5-13, 2021
12021
Thiazolidine derivatives anticancer activity prediction using RDF molecular descriptors
II Myrko, VV Ogurtsov, DV Kaminskiy
Farmatsevtychnyi zhurnal, 50-54, 2010
12010
Anticancer properties of some triazolo [3, 4-b][1, 3, 4] thiadiazoles
I Myrko, T Chaban, Y Horak, V Ogurtsov, I Drapak, I Chaban, V Matiychuk
Current Chemistry Letters 12 (4), 813-820, 2023
2023
Determining the Synthesis, Chemical Modification and Biological Properties of N-acylphenothiazines
I Myrko, T Chaban, Y Matiichuk, M Arshad, V Matiychuk
BP International, 2022
2022
Ñèíòåç ³ äîñë³äæåííÿ ïðîòèïóõëèííî¿ àêòèâíîñò³ äåÿêèõ íîâèõ 7H-[1, 2, 4] òð³àçîëî [3, 4-b][1, 3, 4] ò³àä³àçèí³â
II Myrko, TI Chaban, VV Ohurtsov, IV Drapak, VS Matiichuk
Current issues in pharmacy and medicine: science and practice 14 (3), 320-327, 2021
2021
Synthesis and antitumor properties of some new 3-R-6-(5-arylfuran-2-yl-[1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazoles
I² Myrko, Y² Horak, TI Chaban, ²V Drapak, VS Matiychuk
Farmatsevtychnyi zhurnal, 37-49, 2021
2021
Danylo Halytsky Lviv National Medical University 2 Ivan Franko National University of Lviv
I² Myrko, Y² Horak, TI Chaban, ²V Drapak, VS Matiychuk
ÏÎIJ¯, ÔÀÊÒÈ, 2021
2021
Ëüâ³âñüêèé íàö³îíàëüíèé ìåäè÷íèé óí³âåðñèòåò ³ìåí³ Äàíèëà Ãàëèöüêîãî 2 Ëüâ³âñüêèé íàö³îíàëüíèé óí³âåðñèòåò ³ìåí³ ²âàíà Ôðàíêà
I² MYRKO, Y² HORAK, TI CHABAN, ²V DRAPAK, VS MATIYCHUK
2021
Synthesis and anticancer properties of some N-aryl-2-(5-aryltetrazol-2-yl) acetamides
Ò² Chaban, YE Matiichuk, II Myrko, IG Chaban, VS Matiychyk
Àêòóàëüí³ ïðîáëåìè õ³ì³¿, ìàòåð³àëîçíàâñòâà òà åêîëî㳿, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–18